pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,153 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: phase readout×type: approval×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06789731: Mindfulness-Based Interventions Targeting First-Generation College Student Retention in Rural Environments

    Sponsor: University of South Dakota. Phase: NA. Conditions: Depression, Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03428802: Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

    Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Neoplasm, Metastatic Malignant Solid Neoplasm, POLD1 Gene Mutation, POLE Gene Mutation, Recurrent Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Stage III Breast Cancer AJCC v7, Stage III Ovarian Cancer AJCC v8, Stage IIIA Breast Cancer AJCC v7, Stage IIIA Ovarian Cancer AJCC v8, Stage IIIB Breast Cancer AJCC v7, Stage IIIB Ovarian Cancer AJCC v8, Stage IIIC Breast Cancer AJCC v7, Stage IIIC Ovarian Cancer AJCC v8, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03811002: Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06308653: Psilocybin for Major Depressive Disorder (MDD)

    Sponsor: Usona Institute. Phase: PHASE3. Conditions: Depressive Disorder, Major

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07217353: The Use of a Novel Vaginal Speculum for Endometrial Biopsies

    Sponsor: Rocky Vista University, LLC. Phase: NA. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07366645: Clinical and Cost-Effectiveness of Silver Diamine Fluoride and Silver Fluoride, With or Without Application of LED, in Arresting Incipient Permament Molar Caries

    Sponsor: Cairo University. Phase: NA. Conditions: Incipient Caries

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05523245: Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

    Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: . Conditions: Rectal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07625072: Mental Rehearsal in Emergency Cricothyroidotomy Training

    Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Difficult Airway, Medical Training, Airway Management, Cricothyroidotomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06060977: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

    Sponsor: Inmagene LLC. Phase: PHASE1. Conditions: Alopecia Areata (AA)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04027777: Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation

    Sponsor: Aktiia SA. Phase: NA. Conditions: Blood Pressure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07299877: Perineural Dexamethasone, Dexmedetomidine, or Their Combination to Reduces Rebound Pain After Supraclavicular Brachial Plexus Block

    Sponsor: Al-Azhar University. Phase: PHASE4. Conditions: Brachial Plexus Blocks

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06138275: Elranatamab in R/R Multiple Myeloma

    Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07487857: Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy

    Sponsor: University of Castilla-La Mancha. Phase: NA. Conditions: Cerebral Palsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07633457: Comparison Between Outcomes of Closure of Idiopathic Macular Hole Using Autologus Tenon Capsule Graft and Internal Limiting Membrane Flap Techniques (Pilot Study)

    Sponsor: Ain Shams University. Phase: NA. Conditions: Macular Hole Surgery, ILM Peeling, Tenon Capsule, ILM Flap, Macular Hole

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05753501: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Hematologic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07372157: Neuromuscular Balance Exercise Effects in Overweight and Obese Individuals

    Sponsor: Marmara University. Phase: NA. Conditions: Overweight and Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06245057: Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Morbidity;Perinatal

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07084857: Association Between Isokinetic Lower Extremity Muscle Strength and Bone Mineral Density in Elderly Women With and Without Osteoporosis

    Sponsor: Cairo University. Phase: . Conditions: Osteoporosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06497101: Effectiveness Trial of Temperament Based Therapy With Support (TBT-S)

    Sponsor: Oslo University Hospital. Phase: NA. Conditions: Anorexia Nervosa

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07556601: Ultra-rapid Blastocyst Vitrification: Pilot Randomized Study

    Sponsor: Fundacion Dexeus. Phase: NA. Conditions: Infertility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04799301: Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE1. Conditions: Diet Therapy, Healthy Volunteers

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07541001: PRL3-Zumab in Patients With Advanced Solid Tumors

    Sponsor: Intra-IMMUSG Pte Ltd. Phase: PHASE2. Conditions: Advanced Malignant Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07606001: Yellow Potatoes and Carotenoids

    Sponsor: University of Florida. Phase: NA. Conditions: Carotenoids

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04431479: Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

    Sponsor: Fred Hutchinson Cancer Center. Phase: . Conditions: Chronic Graft Versus Host Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06871579: Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Helicobacter Pylori

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07530588: Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis

    Sponsor: University Hospital of North Norway. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04838288: Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Renal Transplant

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07474688: Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire Procedure

    Sponsor: China-Japan Friendship Hospital. Phase: . Conditions: Uterine Fibroids (Leiomyoma)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06282588: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

    Sponsor: Cancer Research Antwerp. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01969227: The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Mechanical Ventilation, Airway Patency, Respiratory Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

    Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE2. Conditions: Chronic Graft Versus Host Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06545461: Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

    Sponsor: Donald Wesson. Phase: NA. Conditions: Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06037161: Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums

    Sponsor: Case Western Reserve University. Phase: NA. Conditions: Recession, Gingival

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506486: Effect of Immersive Virtual Reality Cognitive Rehabilitation on Subacute Stroke Patients (A Pilot Study)

    Sponsor: Universitas Padjadjaran. Phase: NA. Conditions: Stroke (Subacute)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07336186: The Effect of Virtual Reality-Based Relaxation on Breast Milk Volume and Breastfeeding Self-Efficacy in Mothers of Preterm Infants

    Sponsor: Kocaeli University. Phase: NA. Conditions: Lactation, Breastfeeding, Premature Birth, Maternal Stress, Self-Efficacy

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05089786: Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)

    Sponsor: InSightec. Phase: NA. Conditions: Essential Tremor, Neurology

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07634770: Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

    Sponsor: Sam Chun Dang Pharm. Co. Ltd.. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07610473: A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

    Sponsor: Draig Therapeutics Ltd. Phase: PHASE2. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07619469: Motion Sickness Severity and Sensorimotor Performance

    Sponsor: Istinye University. Phase: . Conditions: Motion Sickness, Somatosensory Disorders, Dizziness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06054269: Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

    Sponsor: Centers for Disease Control and Prevention. Phase: PHASE3. Conditions: Influenza

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07121283: Artificial Intelligence Assisted Bone Age Assessment

    Sponsor: Cheng-Hsin General Hospital. Phase: NA. Conditions: Bone Age

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02530983: Mayo Clinic Upper Digestive Disease Survey

    Sponsor: Mayo Clinic. Phase: . Conditions: Esophageal Neoplasms, Cancer of Esophagus, Cancer of the Esophagus, Esophageal Cancer, Esophagus Cancer, Neoplasm, Esophageal, Esophagectomy, Abnormalities, Digestive System, Digestive System Abnormalities

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04002141: Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis

    Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Endometriosis, Ovarian Hyperstimulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06334354: A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer Survivors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06105541: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder, Ehlers-Danlos Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06940141: Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

    Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07435441: Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke

    Sponsor: Istanbul Arel University. Phase: . Conditions: Post-stroke, Dysphagia, Videofluoroscopy, Scale Reliability Validity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06997094: Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

    Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma, Resectable Head and Neck Squamous-cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06665594: Effect of TXA on Reducing Bruising After Filler Injection

    Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05687266: Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: NSCLC

    full page →ctgov ↗
    ← prev
    page 70 of 104
    next →